U.S. and U.K. Reach Deal on Pharmaceutical Pricing, Tariffs
- December 05, 2025
The Trump administration announced December 1 an agreement in principle with the United Kingdom that would increase the net price its National Health Services (NHS) pays for new medicines by 25% while, in exchange, exempting U.K. drug products from Section 232 tariffs.
ARTICLE TAGS
You must be logged in to access this content.